Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients

BACKGROUND: Prostate cancer (PC) is the second most common cancer among men worldwide. Currently, the most common non-invasive approach for screening and risk assessment of PC is measuring the level of serum prostate-specific antigen (PSA). However, the sensitivity of PSA is 42.8 % and specificity i...

Descripción completa

Detalles Bibliográficos
Autores principales: Brait, Mariana, Banerjee, Mithu, Maldonado, Leonel, Ooki, Akira, Loyo, Myriam, Guida, Elisa, Izumchenko, Evgeny, Mangold, Leslie, Humphreys, Elizabeth, Rosenbaum, Eli, Partin, Alan, Sidransky, David, Hoque, Mohammad Obaidul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362497/
https://www.ncbi.nlm.nih.gov/pubmed/28147335
http://dx.doi.org/10.18632/oncotarget.14873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362497/
https://www.ncbi.nlm.nih.gov/pubmed/28147335
http://dx.doi.org/10.18632/oncotarget.14873

Ejemplares similares